Found: 16
Select item for more details and to access through your institution.
Mesothelial-to-mesenchymal transition as a possible therapeutic target in peritoneal metastasis of ovarian cancer.
- Published in:
- Journal of Pathology, 2017, v. 242, n. 2, p. 140, doi. 10.1002/path.4889
- By:
- Publication type:
- Article
Lymphocyte-specific kinase expression is a prognostic indicator in ovarian cancer and correlates with a prominent B cell transcriptional signature.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 9, p. 1515, doi. 10.1007/s00262-019-02385-x
- By:
- Publication type:
- Article
Targeting Stromal-Cancer Cell Crosstalk Networks in Ovarian Cancer Treatment.
- Published in:
- Biomolecules (2218-273X), 2016, v. 6, n. 1, p. 3, doi. 10.3390/biom6010003
- By:
- Publication type:
- Article
Chromatin-informed inference of transcriptional programs in gynecologic and basal breast cancers.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-12291-6
- By:
- Publication type:
- Article
SIO: A Spatioimageomics Pipeline to Identify Prognostic Biomarkers Associated with the Ovarian Tumor Microenvironment.
- Published in:
- Cancers, 2021, v. 13, n. 8, p. 1777, doi. 10.3390/cancers13081777
- By:
- Publication type:
- Article
Correction: Hu, W., et al. Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype. Cancers 2020, 12 , 2436.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype.
- Published in:
- Cancers, 2020, v. 12, n. 9, p. 2436, doi. 10.3390/cancers12092436
- By:
- Publication type:
- Article
Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) Promotes Uterine Serous Cancer Cell Proliferation and Cell Cycle Progression.
- Published in:
- Cancers, 2020, v. 12, n. 1, p. 118, doi. 10.3390/cancers12010118
- By:
- Publication type:
- Article
ISG15 Promotes ERK1 ISGylation, CD8+ T Cell Activation and Suppresses Ovarian Cancer Progression.
- Published in:
- Cancers, 2018, v. 10, n. 12, p. 464, doi. 10.3390/cancers10120464
- By:
- Publication type:
- Article
Cancer-associated fibroblasts regulate endothelial adhesion protein LPP to promote ovarian cancer chemoresistance.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1.
- Published in:
- Nature Communications, 2016, v. 7, n. 3, p. 11150, doi. 10.1038/ncomms11150
- By:
- Publication type:
- Article
Calcium-dependent FAK/CREB/TNNC1 signalling mediates the effect of stromal MFAP5 on ovarian cancer metastatic potential.
- Published in:
- Nature Communications, 2014, v. 5, n. 10, p. 5092, doi. 10.1038/ncomms6092
- By:
- Publication type:
- Article
Transcriptional regulation of IER3IP1 gene by tumor necrosis factor-α and Sp family proteins.
- Published in:
- Cell Biochemistry & Function, 2010, v. 28, n. 1, p. 31, doi. 10.1002/cbf.1613
- By:
- Publication type:
- Article
Ryanodine receptor 1-mediated Ca<sup>2+</sup> signaling and mitochondrial reprogramming modulate uterine serous cancer malignant phenotypes.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02419-w
- By:
- Publication type:
- Article
Systematic Identification of Druggable Epithelial-Stromal Crosstalk Signaling Networks in Ovarian Cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
ITLN1 modulates invasive potential and metabolic reprogramming of ovarian cancer cells in omental microenvironment.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-17383-2
- By:
- Publication type:
- Article